Down 99%, biotech firm 180 Life Sciences pivots to crypto with ETH bet Post author:MiamiCrypto Post published:July 29, 2025 Post category:Uncategorized The Nasdaq-listed biotechnology firm is raising $425 million for its ETH strategy, joining a parade of penny stocks investing in cryptocurrencies as their business flounders. You Might Also Like Tether buys $459M Bitcoin for Twenty One Capital May 14, 2025 Bitcoin analysts predict $180K to $250K price top in 2025 — Which is most realistic? May 31, 2025 Trump’s next crypto play will be Monopoly-style game — Report April 15, 2025